Flying Kiwis
VC Fund
Flying Kiwis is a VC fund focused on SaaS and 3D Technology. Super-seeded by new entry: Flying Kiwi Angels
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Flying Kiwis invests in
Stages Flying Kiwis invests in
Countries Flying Kiwis invests in
Round sizes
Round size
- Seed
- $5M–$5M
Investment Focus
Industry
- SaaS 1 (50%)
- 3D Technology 1 (50%)
- Medical Device 1 (50%)
- Machine Learning 1 (50%)
- Artificial Intelligence 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Formus
|
Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites acrossANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient. | $5M / Seed / Feb 02, 2022 | |
|
Formus
|
Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites acrossANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient. | $5M / Seed / Feb 01, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Flying Kiwis invest in?
Flying Kiwis invests primarily in SaaS, 3D Technology and Medical Device startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Flying Kiwis's check size?
Flying Kiwis typically joins rounds of $5M–$5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Flying Kiwis participates in.
When did Flying Kiwis last invest?
The most recent investment recorded for Flying Kiwis closed in Feb 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
